In this week's edition of Petri Dish, a Boston cancer biotech is on the hunt for a new CFO, a startup has signed a deal ahead of its IPO and a cancer drug developer raised $175 million.
Hannah Green, Biz Journals
Thu, 10/03/2024 - 2:39am
In this week's edition of Petri Dish, a Boston cancer biotech is on the hunt for a new CFO, a startup has signed a deal ahead of its IPO and a cancer drug developer raised $175 million.